Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ekso Bionics Holdings (EKSO) Capital Leases (2016 - 2017)

Ekso Bionics Holdings has reported Capital Leases over the past 3 years, most recently at $125000.0 for Q1 2017.

  • On a quarterly basis, Capital Leases fell 39.32% to $125000.0 in Q1 2017 year-over-year; TTM through Mar 2017 was $125000.0, a 39.32% decrease, with the full-year FY2016 number at $144000.0, down 36.28% from a year prior.
  • Capital Leases reached $125000.0 in Q1 2017 per EKSO's latest filing, down from $144000.0 in the prior quarter.
  • The five-year high for Capital Leases was $226000.0 in Q4 2015, with the low at $125000.0 in Q1 2017.
  • The 3-year median for Capital Leases is $176000.0 (2016), against an average of $175500.0.
  • Peak YoY movement for Capital Leases: plummeted 36.28% in 2016, then tumbled 39.32% in 2017.
  • Tracing EKSO's Capital Leases over 3 years: stood at $226000.0 in 2015, then plummeted by 36.28% to $144000.0 in 2016, then fell by 13.19% to $125000.0 in 2017.
  • According to Business Quant data, Capital Leases over the past three periods came in at $125000.0, $144000.0, and $166000.0 for Q1 2017, Q4 2016, and Q3 2016 respectively.